journal article·2008-12-10

GFP expression by intracellular gene delivery of GFP-coding fragments using nanocrystal quantum dots

Akiyoshi Hoshino, Noriyoshi Manabe, Kouki Fujioka, Sanshiro Hanada, Masato Yasuhara, Akihiko Kondo, Kenji Yamamoto

Nanotechnology· Volume 19· Issue 49
Publisher page

Abstract

Gene therapy is an attractive approach to supplement a deficient gene function. Although there has been some success with specific gene delivery using various methods including viral vectors and liposomes, most of these methods have a limited efficiency or also carry a risk for oncogenesis. We herein report that quantum dots (QDs) conjugated with nuclear localizing signal peptides (NLSP) successfully introduced gene-fragments with promoter elements, which promoted the expression of the enhanced green fluorescent protein (eGFP) gene in mammalian cells. The expression of eGFP protein was observed when the QD/gene-construct was added to the culture media. The gene-expression efficiency varied depending on multiple factors around QDs, such as (1) the reading direction of the gene-fragments, (2) the quantity of gene-fragments attached on the surface of the QD-constructs, (3) the surface electronic charges varied according to the structure of the QD/gene-constructs, and (4) the particle size of QD/gene complex varied according to the structure and amounts of gene-fragments. Using this QD/gene-construct system, eGFP protein could be detected 28 days after the gene-introduction whereas the fluorescence of QDs had disappeared. This system therefore provides another method for the intracellular delivery of gene-fragments without using either viral vectors or specific liposomes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. 10.1089/104303404136119010.1089/1043034041361190 ↗
2. 10.1089/hum.2006.17.117710.1089/hum.2006.17.1177 ↗
3. 10.1089/10430340332212479210.1089/104303403322124792 ↗
4. 10.1089/10430340276012857710.1089/104303402760128577 ↗
5. 10.1038/7346410.1038/73464 ↗
6. 10.1182/blood-2002-10-329610.1182/blood-2002-10-3296 ↗
7. 10.1212/01.wnl.0000312381.29287.ff10.1212/01.wnl.0000312381.29287.ff ↗
8. 10.1128/JVI.79.2.955-965.200510.1128/JVI.79.2.955-965.2005 ↗
9. 10.1038/nm135810.1038/nm1358 ↗
10. 10.1128/JVI.01253-0710.1128/JVI.01253-07 ↗
11. 10.1089/hum.2008.03310.1089/hum.2008.033 ↗
12. 10.1016/j.ymthe.2005.07.35810.1016/j.ymthe.2005.07.358 ↗
13. 10.1089/hum.1995.6.7-89510.1089/hum.1995.6.7-895 ↗
14. 10.1089/hum.1995.6.12-155310.1089/hum.1995.6.12-1553 ↗
15. Schaffert D · Gene Ther. · 2008
16. 10.1038/sj.cgt.770015610.1038/sj.cgt.7700156 ↗
17. 10.1073/pnas.93.21.1142110.1073/pnas.93.21.11421 ↗
18. 10.1038/sj.gt.330271510.1038/sj.gt.3302715 ↗
19. 10.1006/mthe.2002.064710.1006/mthe.2002.0647 ↗
20. 10.1248/yakushi.127.80710.1248/yakushi.127.807 ↗
21. 10.1016/j.addr.2005.09.01710.1016/j.addr.2005.09.017 ↗
22. 10.3390/1001003410.3390/10010034 ↗
23. 10.1038/sj.mt.630021810.1038/sj.mt.6300218 ↗
24. 10.1038/sj.gt.330294510.1038/sj.gt.3302945 ↗
25. Hsieh J M · Chem. Commun. · 2006 · 61510.1039/b517368j ↗
26. 10.1038/nm109610.1038/nm1096 ↗
27. 10.1126/science.107719410.1126/science.1077194 ↗
28. 10.1007/s12282-008-0037-010.1007/s12282-008-0037-0 ↗
29. 10.1073/pnas.15246339910.1073/pnas.152463399 ↗
30. 10.1038/nbt92010.1038/nbt920 ↗
31. Hoshino A · J. Immunol. · 2007 · 178 · 529610.4049/jimmunol.178.8.5296 ↗
32. Hoshino A · Microbiol. Immunol. · 2007 · 51 · 55110.1111/j.1348-0421.2007.tb03933.x ↗
33. Ebbesen M · J. Biomed. Biotechnol. · 2006 · 2006 · 5151610.1155/JBB/2006/51516 ↗
34. 10.1016/j.ijsu.2005.10.00710.1016/j.ijsu.2005.10.007 ↗
35. 10.1016/j.copbio.2007.01.00610.1016/j.copbio.2007.01.006 ↗
36. Navalakhe R M · Indian J. Exp. Biol. · 2007 · 45 · 160
37. Arayne M S · Pak. J. Pharm. Sci. · 2006 · 19 · 258
38. Lin H · Natl Med. J. India · 2006 · 19 · 27
39. Hoshino A · J. Med. Technol. · 2006 · 50 · 1409
40. Hoshino A · Microbiol. Immunol. · 2004 · 48 · 98510.1111/j.1348-0421.2004.tb03621.x ↗
41. 10.1016/j.biomaterials.2004.06.03910.1016/j.biomaterials.2004.06.039 ↗
42. 10.1073/pnas.050492610210.1073/pnas.0504926102 ↗
43. 10.1021/nl071114c10.1021/nl071114c ↗
44. 10.1021/la701270510.1021/la7012705 ↗
45. 10.1016/j.ymthe.2006.03.01010.1016/j.ymthe.2006.03.010 ↗
46. Matsushita M · J. Neurosci. · 2001 · 21 · 600010.1523/JNEUROSCI.21-16-06000.2001 ↗
47. 10.1016/j.bbrc.2003.11.18510.1016/j.bbrc.2003.11.185 ↗
48. 10.1021/nl048715d10.1021/nl048715d ↗
49. 10.1007/s10047-007-0379-y10.1007/s10047-007-0379-y ↗
50. Fujioka K · Nanotechnology · 2008 · 19 · 41510210.1088/0957-4484/19/41/415102 ↗
51. Shiohara A · Microbiol. Immunol. · 2004 · 48 · 66910.1111/j.1348-0421.2004.tb03478.x ↗
52. 10.1117/1.276760810.1117/1.2767608 ↗
53. 10.1016/S0006-291X(03)00211-010.1016/S0006-291X(03)00211-0 ↗
54. 10.1289/ehp.828410.1289/ehp.8284 ↗